Physician profile
Keith Kreitz
NPI 1336101591
$10,093.16
in general payments reported to CMS, 2019-2025
16 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,922 · 2020: $2,298 · 2021: $98.24 · 2022: $455 · 2023: $43.97 · 2024: $40.74 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $9,106.18 | 2019-2022 | |
| Intuitive Surgical, INC. | $378.61 | 2022 | |
| Aroa Biosurgery Incorporated | $153.14 | 2025 | |
| Solventum Corporation | $81.98 | 2025 | Activ.A.C. |
| Ethicon US, LLC | $68.17 | 2019-2020 | |
| Stryker Corporation | $51.17 | 2023-2024 | 1788 |
| Novo Nordisk INC | $37.37 | 2019-2022 | |
| Baxter Healthcare | $34.83 | 2021 | |
| Innovation Technologies INC | $34.62 | 2021 | |
| Mallinckrodt Enterprises LLC | $33.48 | 2019 | |
| Intra-Sana Laboratories | $27.74 | 2022-2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Standard Bariatrics, INC. | $22.39 | 2022 | |
| Mimedx Group, INC. | $20.19 | 2024 | |
| Apollo Endosurgery US INC | $14.67 | 2019 | |
| Shire North American Group INC | $14.50 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Kreitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.